← All trials
NCT04854395
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 9, 2021
- Primary completion
- Mar 1, 2024
- Completion date
- Mar 1, 2024
- First posted
- Apr 22, 2021
- Last posted
- Apr 26, 2021
- Enrollment
- 165
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hospitalsenhed MidtLead sponsor
- Hospitalsenhed MidtReponsible party - principal investigator
- Hospitalsenhed MidtOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.